Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Malignant Lymphoma

  Free Subscription


1 Blood
1 BMC Cancer
1 Br J Haematol
1 Cancer
1 J Clin Oncol
1 Leuk Lymphoma

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles


  1. RAUCH DA, Conlon KC, Janakiram M, Brammer JE, et al
    Rapid Progression of Adult T-Cell Leukemia/Lymphoma as Tumor Infiltrating Treg Cells after PD-1 Blockade.
    Blood. 2019 Aug 29. pii: blood.2019002038. doi: 10.1182/blood.2019002038.
    PubMed     Text format     Abstract available

    BMC Cancer

  2. CHENG Y, Xiao Y, Zhou R, Liao Y, et al
    Prognostic significance of helicobacter pylori-infection in gastric diffuse large B-cell lymphoma.
    BMC Cancer. 2019;19:842.
    PubMed     Text format     Abstract available

    Br J Haematol

  3. PASSERO FC JR, Ravi D, McDonald JT, Beheshti A, et al
    Combinatorial ixazomib and belinostat therapy induces NFE2L2-dependent apoptosis in Hodgkin and T-cell lymphoma.
    Br J Haematol. 2019 Aug 26. doi: 10.1111/bjh.16160.
    PubMed     Text format     Abstract available


  4. GANGARAJU R, Chen Y, Hageman L, Wu J, et al
    Risk of venous thromboembolism in patients with non-Hodgkin lymphoma surviving blood or marrow transplantation.
    Cancer. 2019 Aug 30. doi: 10.1002/cncr.32488.
    PubMed     Text format     Abstract available

    J Clin Oncol

  5. TOBIN JWD, Keane C, Gunawardana J, Mollee P, et al
    Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration.
    J Clin Oncol. 2019 Aug 28:JCO1802365. doi: 10.1200/JCO.18.02365.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  6. MOREIRA J, Platanias LC, Adekola KUA
    It's all about the CD3+ T-cells: how circulating immune cell subset analyses can predict early relapse in Hodgkin lymphoma.
    Leuk Lymphoma. 2019 Aug 27:1-3. doi: 10.1080/10428194.2019.1646909.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.